Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

2.6

Antenatal Fetal Surveillance

Obstetrics & Gynaecology Protocols, Version 3.0, 2017. Chapter 2, Labour Ward.

Clinical description

Fetal surveillance aims to evaluate fetal well-being. During antenatal care, the fetal heart is assessed using a fetoscope (≥ 20 wks gestation) or Doppler (≥ 12 wks gestation). For abnormalities or complicated pregnancies, use cardiotocogram (CTG), non stress test (NST), or biophysical profile (BPP).

Method Indication/ Procedure Interpretation and Management Non Stress Test Indications:all pregnant women at risk for • Reactive test has ≥ 2 accelerations (15 bpm above baseline x 15 sec) in 20 (NST) intrauterine fetal compromise minutes with moderate variability and baseline range from 110- 160 bpm

  • Prolonged pregnancy • Non-reactive test requires BPP
  • Maternal hypertensive disorders
  • Diabetes mellitus
  • RH sensitization
  • Maternal hemoglbinopathies
  • Renal disease
  • Fetal anomalies
  • Poor prior obstetric history
  • Reported decrease in perceived fetal

movements Procedure:

  • Place CTG on abdomen for ≥ 20 min
  • Observe up to 40 min if non-reactive (may be

due to fetal sleep cycle or normal period of fetal inactivity) Biophysical Use NST and real-time U/S to evaluate: • Assign 2 points if present and 0 points if absent for US components Profile (BPP) • Fetal breathing (1 breathing cycle ≥ 30 sec • Assign 2 points if reactive NST and 0 points if non-reactive NST during 30 min period) • Score ≤ 6 (out of 10) is suspicious for fetal hypoxemia

  • Gross body movements (3 discrete body or limb •

movements)

  • Fetal tone (1 episode of extension or flexion of

limbs or trunk, or opening or closing of hand)

  • Amniotic fluid volume (1 pocket ≥ 2 cm in 2

perpendicular planes) Modified BPP BPP is labour intensive; therefore, modified BPP • Normal if AFI > 5 cm and reactive NST may be used:

  • Amniotic Fluid Index (AFI) with NST

Clinical description

Intrapartum fetal • Evaluate fetal heart rate for ≥ 1 min for all • Requires CTG/Moyo heart monitoring women in admission with fetoscope or Doppler • Normal includes fetal heart rate that increases or decreases with contraction but

  • Evaluate fetal heart rate before, during, and after recovers to baseline after contraction

a contraction every 30 min of active phase of • Abnormal includes bradycardia, tachycardia, and decelerations in the absence of labour a contraction or persisting after a contraction:

  • Record fetal heart rate in active phase on o Evaluate for maternal fever, hypotension, and medications

partograph o Evaluate for placental abruption and chorioamnionitis Cardiotocogram Indications: • Normal includes (CTG)/Moyo • Augmentation with Oxytocin o Baseline rate of 110-160 bpm with variability of 5-25 bpm monitoring • Induction of labour with Misoprostol after each o Accelerations administration of Misoprostol and at onset of o Early decelerations (often due to fetal head compression) contractions • Abnormal includes

  • Pprolonged labour o Late decelerations (suspicious for fetal hypoxia and acidosis due to
  • Suspicion of fetal distress on FHR auscultation placental insufficiency)
  • Oligohydramnios o Sinusoidal if fetal anaemia
  • IUGR o Variable decelerations (often due to cord compression and may not require

intervention)

  • Preterm delivery
  • Management of abnormal CTG
  • Previous caesarean in active phase of labour
  • Evaluate for possible aetiology

awaiting theatre (or VBAC)

  • Place woman in left lateral position
  • Meconium stained liquor
  • Stop oxytocin if applicable
  • Treat with tocolytic (i.e,. nifedipine) if hyperstimulation (> 5

Procedure contractions in 10 min)

  • Place fetal heart monitor on abdomen so
  • Treat with NS 500 ml IV bolus if hypotension

that heart beat is detected easily

  • Treat with oxygen by mask if available
  • Place monitor for detection of contractions at
  • Elevate the presenting part if cord prolapse

top of the fundus

  • Consider Caesarean or operative vaginal delivery

Fetal surveillance in the absence of CTG/Moyo monitoring:

For all pregnancies:

  • Determine gestational age and SFH at every visit; if discrepancy ultrasound scan for fetal growth, AFI if possible
  • Refer if abnormal fetal growth or abnormal liquor
  • Auscultate FHR at every antenatal visit
  • Ask patient about perceived fetal movements

For high risk pregnancies:

  • Refer to tertiary hospital

If Gestational age is 40 weeks and above, please see protocol for Post-Term Pregnancy.

Tables and figures

Figure from the guideline
Table, page 30 of the printed guideline. Open the image to zoom.
Figure from the guideline
Table, page 31 of the printed guideline. Open the image to zoom.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.